Wave 80 Biosciences, Inc. – Product Pipeline Analysis, 2015 Update

Date: 2016-01


Wave 80 Biosciences, Inc. (Wave 80) is a medical technology company that develops molecular diagnostic instruments and consumables for the clinical laboratory testing systems markets. It develops molecular diagnostics instruments for chlamydia, respiratory illness, cancers, autoimmune diseases, hepatitis B, hepatitis C, HIV/AIDS and other human health conditions. The company’s technology is the EOSCAPE molecular diagnostics system, which facilitates provision of molecular testing in smaller hospitals and clinics. Its lead product, EOSCAPE-HIV, is an in vitro nucleic acid assay, which enables the detection and quantitation of human immunodeficiency virus type 1 (HIV-1) RNA. Wave 80 product pipeline comprises assays for infectious and non-infectious diseases such as EOSCAPE-HBV DNA, EOSCAPE-HIV RNA PLUS, EOSCAPE-TB, EOSCAPE-TB-DST, EOSCAPE-HBV DNA PLUS, EOSCAPE-HCV RNA and EOSCAPE-STD. Wave 80 is headquartered in San Francisco, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


– The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
– The report analyzes all pipeline products in development for the company Wave 80 Biosciences, Inc.
– The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
– The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
– The report provides detailed description of products in development, technical specification and functions
– The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

– Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
– Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
– To formulate effective Research & Development strategies
– Develop market-entry and market expansion strategies
– Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
– Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
– Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio”

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample